Related Experiment Videos
Right Dose, Right Now: Customized Drug Dosing in the Critically Ill
Jason A Roberts1, Anand Kumar, Jeffrey Lipman
11Burns, Trauma and Critical Care Research Centre, School of Medicine, The University of Queensland, Brisbane, Queensland, Australia. 2Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. 3Pharmacy Department, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. 4Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia. 5Sections of Critical Care Medicine and Infectious Diseases, Health Sciences Centre/St. Boniface Hospital, Departments of Medicine, Medical Microbiology and Pharmacology, University of Manitoba, Winnipeg, Manitoba, Canada.
Optimizing antibiotic dosing for critically ill patients can improve cure rates and reduce mortality. Customized dosing regimens, initiated promptly, are crucial for better patient outcomes and combating antimicrobial resistance.
Area of Science:
- Critical care medicine
- Infectious diseases
- Pharmacology
Background:
- Antibiotics are vital for treating infections in critically ill patients.
- Despite advances, poor outcomes persist for infected critically ill patients.
- Optimizing antibiotic therapy is essential for further improvement.
Purpose of the Study:
- To highlight the need for a new approach to antibiotic therapy in critical care.
- To emphasize the benefits of customized antibiotic dosing for clinical cure and resistance suppression.
- To advocate for the integration of optimized dosing strategies into daily practice.
Main Methods:
- Discusses the potential of customized dosing regimens using nomograms or software.
- Highlights the importance of therapeutic drug monitoring.
- Stresses the need for prompt initiation of antibiotic therapy, especially in septic shock.
Main Results:
- Customized dosing likely increases clinical cure probability and suppresses resistance.
- Optimized dosing may reduce mortality in severely ill patients.
- Reduced time to therapy improves survival, particularly in septic shock.
Conclusions:
- A new approach to antibiotic therapy, focusing on customized dosing, is needed.
- Evidence-based nomograms or software with therapeutic drug monitoring should be standard practice.
- Large prospective studies are required to validate the benefits of customized antibiotic dosing on patient survival and costs.